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Abstract
Background: Cancer survivors are often left on their own to deal with the challenges of resuming work during or
after cancer treatment, mainly due to unclear agreements between stakeholders responsible for occupational
rehabilitation. Social inequality exists in cancer risk, survival probability and continues with regard to the chance of
being able to return to work.
The aim is to apply an early, individually tailored occupational rehabilitation intervention to cancer survivors in two
municipalities parallel with cancer treatment focusing on enhancing readiness for return to work.
Methods/Design: In a controlled trial municipal job consultants use acceptance and commitment therapy
dialogue and individual-placement-and-support-inspired tools with cancer survivors to engage them in behaviour
changes toward readiness for return to work. The workplace is involved in the return to work process.
Patients referred to surgery, radiotherapy or chemotherapy at the Oncology Department, Aarhus University Hospital,
Denmark for the diagnoses; breast, colon-rectal, head and neck, thyroid gland, testicular, ovarian or cervix cancer
are eligible for the study. Patients must be residents in the municipalities of Silkeborg or Randers, 18–60 years of
age and have a permanent or temporary employment (with at least 6 months left of their contract) at inclusion.
Patients, for whom the treating physician considers occupational rehabilitation to be unethical, or who are not
reading or talking Danish are excluded. The control group has identical inclusion and exclusion criteria except for
municipality of residence.
Return to work is the primary outcome and is indentified in a social transfer payment register. Effect is assessed as
relative cumulative incidences within 52 weeks and will be analysed in generalised linear regression models using
the pseudo values method. As a secondary outcome; co-morbidity and socio-economic status is analysed as effect
modifiers of the intervention effect on return to work.
Discussion: The innovative element of this intervention is the timing of the occupational rehabilitation which is
much earlier initiated than usual and the active involvement of the workplace. We anticipate that vulnerable cancer
survivors will benefit from this approach and reduce the effects of social inequality on workability.
Trial registration: Current Controlled Trials ISRCTN50753764. Registered August 21st, 2014.
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Background
Cancer and return to work
Cancer prevalence has increased worldwide in recent
years due to improvements in diagnostic procedures and
treatment [1]. Approximately 40 % of new cancers are
found in the working population [2], of whom many are
motivated for and expect to return to work (RTW) [3], as
RTW constitutes “normalcy”, has impact on quality of life
and economic independence [4, 5]. However, the cancer
disease and the treatment still increases the risk of early
withdrawal from the labour market [6, 7]. Even though
work is perceived as an important factor in quality of life
[8, 9], for some cancer survivors work participation may
be deprioritised by other ways of active participation in so-
ciety [10]. Therefore knowledge on how cancer survivors
value their work and how this affects the RTW process is
needed. Among cancer survivors who do RTW some may
face both health-related and work-related difficulties lead-
ing to reduced workability and recurrence of sick leave
[11], which further increases the risk of prematurely exit
from the labour market [12]. Some consistency exists in
the literature about which factors are associated with
RTW despite adverse side-effects from cancer treatment
[13]. However, often cancer patients are left on their own
to deal with these challenges [11, 14, 15, 10]; partly due to
unclear agreements between stakeholders responsible for
occupational rehabilitation [10, 16] and partly due to re-
luctance and fear of articulating work and RTW to a can-
cer survivor [17].
Research on RTW in cancer survivors has in recent
years increased, partly because survival rates have in-
creased [18, 19], and because patients with advanced, in-
curable disease are able to perform some kind of work,
and will often prefer to stay on the labour marked as
long as possible. Nevertheless, there still is a need for
rigorous studies applying a randomised controlled trial
design, with thorough information on intervention com-
ponents and data reporting [19]. Due to the inconsistent
conclusions drawn from the existing RTW studies in
cancer survivors; evidence from research conducted on
musculoskeletal and/or mental-related sickness absen-
tees can give insights into effective RTW interventions
in general and guide researchers in putting hypotheses
forward on which elements cancer-oriented RTW inter-
ventions may contain. Thus, the provision of occupa-
tional rehabilitation to cancer survivors that consists of
a combination of general and cancer specific interven-
tion elements may prove to be an effective approach.
Some evidence supports that RTW interventions tar-
geted musculoskeletal-related [20] or depressed absen-
tees [21] are more effective when they address the
workplace than interventions not targeting the work-
place. Thus, in the planning of the present study it was
crucial to incorporate involvement of the workplace as
one of the key elements in the intervention. In a cancer
setting it has been shown that employer and colleague
support as well as work accommodation increases the
RTW rate and reduces the likelihood of cancer-related
work impairments after RTW [13].
Problem-solving-therapy interventions towards em-
ployees sick-listed due to adjustment disorders enhanced
partial RTW compared to a non-guideline based care
[22]. Cancer survivors may also display adjustment dis-
orders due to difficulties in coping with having a cancer
diagnosis along with expectations from relatives and
friends, workplace and health care professionals in the
RTW process. Fear of cancer recurrence may lead to fear
avoidance behaviour, which limits participation in life -
including work [23, 24]. Therefore, the identification of
cancer survivor-experienced barriers regarding RTW
and assistance in barrier modification were important el-
ements that the present intervention should include.
Feuerstein et al. developed the Work and Cancer
Model based on an extensive review of the literature
[25]. A variety of factors coexists and may act both as fa-
cilitators and inhibitors of RTW among cancer survivors;
individual characteristics, health and well-being, symp-
toms, function, work demands, work environment and
finally structural factors [25]. There seems to be agree-
ment in the literature that RTW-interventions in general
should target the multi-dimensional factors that are as-
sociated with sickness absence and that seems also to be
true in a cancer specific context. This perspective is in
part substantiated in the Cochrane review by de Boer
et al. on RTW interventions to cancer survivors. Al-
though the studies had low quality it was concluded that
one-dimensional interventions, i.e. psychological, phys-
ical or medical interventions did not improve RTW
compared to care as usual, whereas a moderate quality
evidence was found for a multidisciplinary approach (in-
volving physical, psychological and vocational elements)
compared to care as usual [18].
Cancer survivors in low socioeconomic groups may in
particular experience the RTW-process difficult and
tend to be at risk of recurrent sickness absence, un-
employment or permanent withdrawal from the labour
market [7, 26, 27]. It is not clear which role socioeco-
nomic status plays on cancer survivors’ RTW-process,
but unfavourable work conditions characteristic for low
income and low-level educational jobs may explain some
of this inequality [28]. Therefore work accommodations
and supervisor support may be of particular import-
ance in occupational rehabilitation in cancer survivors
[3, 10, 29] to help cancer survivors overcome the im-
balance between health and work demands.
Despite improved long-term survival rates for cancer
patients, survivorship does not mean living without health
complaints, but rather living with a chronic disease [30].
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Cancer survivors do have an increased risk of recurrent
cancers along with co-morbidities like cardiovascular dis-
ease, diabetes, osteoporoses etc. [31]. This further in-
creases the risk for reductions in workability and calls for
collaboration between the occupational rehabilitation
stakeholders to enhance the chance of sustainable RTW.
The Danish healthcare system
Permanent residents in Denmark pay approximately 40-
50 % taxes of their income, by which almost all examina-
tions and treatments within the Danish healthcare system
are free of charge. The Danish Health and Medicines
Authority is responsible for the organizational and clin-
ical standards for the diagnostics and treatment for all
cancer types, i.e. integrated cancer pathways [16]. The
objective of the pathways is to reduce referral time, ob-
tain faster diagnosing and early onset of treatment. To
accomplish these general goals the pathways are opera-
tionalised in several Disease Management Programmes
for Cancer of which one defines Rehabilitation and
Palliation in Cancer [16]. The specific aim of cancer re-
habilitation is, besides optimizing the patient's physical,
psychological and social functioning while countering
the limitations imposed by the side effects of cancer treat-
ments and/or co-morbid conditions, also to offer occupa-
tional and vocational rehabilitation [32]. Few studies have
been conducted on occupational rehabilitation offered
parallel to cancer treatment at the hospital [33, 34], how-
ever more studies are ongoing/in preparation [35–37].
Thus, knowledge is scarce on whether occupational re-
habilitation applied early and parallel to cancer treatment
facilitates the RTW-process for cancer survivors. To our
knowledge, no studies have been conducted in a Danish
setting or in other Nordic countries, which has similar
tax-financed health care systems as Denmark.
Sickness absence management in Denmark
According to the Danish Sickness Benefit Act [38], the
municipal job centres are responsible for paying sickness
benefits and initiating occupational/vocational rehabilita-
tion to help sick-listed persons to RTW.
All employed, self-employed, temporarily employed
and unemployed persons fulfilling the criteria of previ-
ous employment (minimum 74 h within a period of
8 weeks) are eligible for sickness benefits.
According to law, the employer pays sickness benefits
during the first 4 weeks, afterwards the municipality
refunds the employer’s wage expenses for a maximum
period.
The regulations for sickness benefits have been subject
to several changes [39] and continue to be so. When the
study started the maximum period was 52 weeks within
a period of 78 weeks. From July 2014 the maximum
period in general was reduced to 26 weeks. However,
extensions can be granted and for persons suffering
from cancer the maximum period may be unlimited.
Medical certificates were not mandatory but could be
requested by the municipal social security system and the
employer. However, from January 2015 a medical certifi-
cate became obligatory after 8 weeks of sickness absence.
After the newest reform in 2014–15 the sickness bene-
ficiaries are assigned into three categories: Category 1
includes persons who are likely to RTW within eight
weeks without intervention. Category 2 includes persons
who are unlikely to RTW within eight weeks unless ac-
tivities facilitating RTW are initiated, i.e. coping-sessions
and graded RTW. Category 3 includes persons who are
unlikely to RTW within eight weeks unless multidiscip-
linary rehabilitation is implemented. This is planned by
a municipal rehabilitation team within 12 weeks.
In accordance with the law sickness benefit officers are
obliged to conduct regular follow-up interviews at least
every four weeks with beneficiaries in category 2 and 3.
Thus, municipal officers have been appointed the role as
case managers, whereas employers have little responsi-
bility for sickness absence management after they have
had the first obligatory meeting with the employee after
four weeks of sick-listing.
Most cancer survivors may be assigned in category 2,
but in reality they are often spared the obligatory meet-
ings with the social security officer and activities initi-
ated by the job centre while receiving their treatment.
This leads to a short time frame in which the cancer sur-
vivors are offered vocational/occupational rehabilitation;
i.e. time between the end of treatment and the max-
imum period of sickness benefit reimbursement. Offer-
ing early occupational rehabilitation parallel to cancer
treatment focusing on preparations for RTW and mak-
ing arrangements together with the employer regarding
work accommodations, graded RTW etc. should im-
prove the RTW-process and reduce the recurrent sick-
ness absence after RTW.
Readiness for return to work scale
RTW after long-term sickness absence may be seen as a
behavioural change or a process in several stages [40],
depending on factors of which the person’s own RTW
perceptions are predictive of future work participation
[41–43]. The Readiness for RTW (R-RTW) scale [40] is
based on the original stages of change model [44], which
have been applied to various behaviours and across di-
verse disorders [45].
The R-RTW model addresses the motivational and so-
cial factors contributing to RTW behaviour and main-
tenance of work participation [46]. According to this
model, the person progresses through stages of behav-
iour change i.e. RTW after sickness absence, shifting
from the intention not to engage in RTW behaviour in
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the foreseeable future to a stage with initiating behaviour
change, to maintain behaviour change and to RTW in a
sustainable fashion.
Based on the score of the R-RTW scale it is possible
to identify a person’s stage of readiness for change with
regard to RTW allowing professionals, e.g. job consul-
tants to tailor effective and individual support.
Aim and hypotheses
The objectives are to apply an early, individually tailored
occupational rehabilitation intervention to cancer survi-
vors in two municipalities parallel with cancer treatment
focusing on enhancing the R-RTW.
Two hypothesises;
a) this early intervention conducted by a municipal job
consultant will enhance the readiness for RTW and
thereby increase the chance of RTW among cancer
survivors from two municipalities compared with
cancer survivors from municipalities not receiving
this intervention but treated at the same hospital
and receiving the standard municipal sick leave
management.
b) that socioeconomic status and/or co-morbidity will
modify the effect of the intervention on RTW.
Methods/Design
Trial design
The study is a controlled trial conducted on cancer sur-
vivors treated at the Oncology Department, Aarhus
University Hospital, Denmark with a 12 months follow-up.
Participants
Intervention group
Cancer patients diagnosed with breast, colon-rectal,
head and neck, thyroid gland, testicular, ovarian or
cervix cancer referred to surgery, radiotherapy or
chemotherapy at the Oncology Department at Aarhus
University Hospital. Patients must be residents in the
municipalities of Silkeborg or Randers, be at the age
of 18–60 years and have a permanent or temporary
employment (with at least 6 months left of their con-
tract) at the inclusion date. Patients are eligible for
participation whether they are still working or being
on sick leave.
Patients, for whom the treating physician considers oc-
cupational rehabilitation to be unethical, or who are not
reading or talking Danish are excluded.
Recruitment started in December 2013 and continues
until the required sample size is obtained.
Control group
The control group is defined by patients with identical
inclusion and exclusion criteria as the intervention
group except that they live in other municipalities than
Silkeborg and Randers.
The control group is identified via the electronic pa-
tient records at the Aarhus University Hospital.
Recruitment of the intervention group participants
Patients are recruited to the intervention group in a
three-stage process:
1) At each cancer ward a nurse or assistant nurse
assigned to this project identifies patients living in
Randers or Silkeborg municipality with the eligible
cancer diagnosis.
2) The treating oncologist is notified of this patient and
at first given consultation the patient is informed
about the project, is handed a written information
sheet also containing an informed written consent
formula. The patient is asked to read the information
sheet and is informed that a municipal job consultant
will contact the patient at home by phone.
2a)The municipal job consultant may also identify
eligible patients even before cancer treatment has
begun because of sick leave spells exceeding 8 weeks.
In that case the treating hospital ward is notified
about inclusion status; in that way no cancer
survivor is asked twice about inclusion.
3) Finally the patient is telephoned by the municipal
job consultant, who thoroughly informs the patient
about the project. Participation includes the patients’
willingness to involve next of kin, employer, and
colleagues. If the patient accepts participation the
first meeting is set up and the informed written
consent formula is signed on that occasion.
Intervention
Control group
Cancer survivors in the control group will receive the
usual municipal sickness benefit management within their
municipal of residence as described in the background.
Intervention group
In both intervention municipalities the two job con-
sultants attended a 4-days course in which they were
specially trained by a psychologist in using elements
of the Acceptance and Commitment Therapy (ACT)
[23, 47] and the Individual Placement and Support
Model (IPS) [48, 49].
During the inclusion- and intervention period the job
consultants receive supervision by this psychologist once
every month to secure a high degree of compliance with
the intervention protocol.
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Acceptance commitment and therapy
ACT is a development of cognitive behaviour therapy,
which is based on recognition of the person’s values and
immediate needs in current life situation. The goal of
ACT is to increase psychological flexibility, which can
be defined as the ability to contact the present moment
more fully as a conscious human being, and to change
or persist in behaviour that support one’s own values.
Psychological flexibility is established through six core
ACT processes: acceptance, cognitive fusion, being
present, self as context, values, and committed action.
Each of these areas is conceptualized as a positive psy-
chological skill. The survivors are through dialogue with
the job consultant confronted with these six core ele-
ments in order to enhance commitment and change in
behaviour towards RTW [23].
Individual placement and support
The IPS inspired the way the job consultants systematize
the actions by which they support RTW. The model
originates from helping people with severe psychiatric
illness to engage in paid employment, and builds on the
following key elements: integration at the workplace,
paid work, individualized services, and an ongoing indi-
vidualised support [48, 49]. In this intervention the indi-
vidualised support is “operationalised” in a number of
phases, which correspond to the R-RTW obtained stages
of change, i.e. a set of IPS-inspired actions are initiated
according to the defined stage in which the survivor per-
ceives him-/herself to be in: Pre-contemplation, Con-
templation, Preparation for action - self-evaluative,
Prepared for action – behavioural, Uncertain mainten-
ance, or Proactive maintenance.
Assessment of occupational rehabilitation needs
At the first meeting with the job consultant the cancer
survivor is asked to answer an online questionnaire. The
questionnaire data is used to guide the job consultant re-
garding the cancer survivor’s readiness for RTW and
need of support in order to set up an individual RTW
plan. Hence, the ACT inspired dialogue and the system-
atic occupational needs assessment are integrated in the
IPS phases by which the job consultant supports the sur-
vivor’s RTW-process (Fig. 1). The job consultant sets up
meetings with the cancer survivor according to the
RTW plan. Throughout the intervention the rehabilita-
tion plan is adjusted to the survivors’ needs, actual re-
sources and readiness for RTW. The initial rehabilitation
plan and the subsequent actions and adjustments are
registered online alongside the questionnaire data by the
job consultants.
The intervention continues for a maximum of one year
or until RTW. The survivor answers the Readiness for
RTW scale after three months and at one-year follow up.
Online questionnaire
Co-morbidity
Eighteen co-morbidity questions asking whether the re-
spondent suffer from or has suffered from (asthma,
allergies, diabetes, hypertension, coronary thrombosis, an-
gina, cerebral thrombosis, chronic obstructive pulmonary
disease, osteoarthritis, rheumatoid arthritis, osteoporosis,
cancer, migraine, minor psychiatric disorder, major psychi-
atric disorder, herniated disc or other back disorders, cata-
ract, tinnitus). There are four response categories (no/
never, yes/present, yes/previously, if previously yes - do
you have any late complications?). Number of co-
morbidities are counted if present or previously present
and give late complications [50, 51].
Work intention
One question about intention to work (i) in your esti-
mation, what are the chances that you will be able to
work in six months?” measured with a 10-point rating
scale ranging from 1 (no chance) to 10 (very large
chance) [52].
Self-efficacy
The seven-item general self-efficacy scale from The
Copenhagen Psychosocial Questionnaire (COPSOQ) (i) I
can always manage to solve difficult problems if I try
hard enough, (ii) if someone opposes me, I can find the
ways and means to get what I want, (iii) I am certain
that I can accomplish my goals, (iv) thanks to my re-
sourcefulness, I can handle unforeseen situations, (v) I
can remain calm when facing difficulties because I can
rely on my coping abilities, (vi) when I am confronted
with a problem, I can find several solutions, (vii) I can
handle whatever comes my way. The response categories
are (not at all true, barely true, moderately true, and
exactly true) which were scored from 0–100 with 100
representing the highest degree of self-efficacy [53].
Social support
From the 2nd version of COPSOQ, three items about
social support from colleagues and supervisors, respect-
ively; (i) how often do you get help and support from
your colleagues?, (ii) how often are your colleagues will-
ing to listen to your problems at work?, (iii) how often
do your colleagues talk with you about how well you
carry out your work? and (i) how often is your nearest
superior willing to listen to your problems at work?, (ii)
how often do you get help and support from your near-
est superior?, (iii) how often does your nearest superior
talk with you about how well you carry out your work?.
The response categories are (always; often; sometimes;
seldom; never/hardly ever; not relevant, which are
scored from 0–100 with 100 representing the highest
degree of support [54].
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Fig. 1 The structure used by the job consultants to tailor and support the return to work process. The individual rehabilitation plan is tailored
according to different stages of readiness for return to work (R-RTW) and corresponding individual placement and support (IPS) actions that the
job consultant initiates accompanied by acceptance and commitment therapy (ACT) inspired dialogue that should enhance commitment and
change behaviour towards return to work (RTW)
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Readiness for RTW
Finally, the Readiness for RTW will be measured by the
Danish version of the original R-RTW scale [40]. The in-
strument consists of two scales; 22 items for persons not
yet returned to work: (i) you do not think you will ever
be able to go back to work?, (ii) you have been making
plans with someone from your workplace to return back
to work?, (iii) you have been thinking about making
some changes that will help you go back to work?, (iv)
as far as you are concerned there is no point in thinking
about returning to work?, (v) you have learned different
ways to cope with your pain so you can return to work?,
(vi) you are actively doing things now to get back to
work?, (vii) you think you might be ready to go back to
work?, (viii) you are planning to go back to work, even if
your pain is not 100 % gone?, (ix) physically, you are
starting to feel ready to go back to work?, (x) you have
been increasing your activities at home in order to build
up your strength to go back to work?, (xi) you are get-
ting help from others to return to work?, (xii) you are
not ready to go back to work?, (xiii) you have found
strategies to make your work manageable so you can re-
turn to work?, (xiv) mentally, you are starting to feel
ready to go back to work?, (xv) you have been wonder-
ing if there is something you could do to return to
work?, (xvi) you worry about having to stop working
again due to your injury?, (xvii) you have started think-
ing about going back to work”?, (xviii) you have a date
for your first day back at work?, (xix) you wonder if you
will be able to go back to work?, (xx) you wish you had
more ideas about how to get back to work?, (xxi) you
would like to have some advice about how to go back to
work?, (xxii) as far as you are concerned, you do not
need to go back to work ever”?.
And a scale with 12 items for those who have returned
to work (part-time or full-time), but are at risk of sick-
ness absence relapse: (i) you are trying different strat-
egies to stay at work?, (ii) you are doing everything you
can to stay at work?, (iii) you are getting help from
others to stay at work?, (iv) you are working hard to find
ways to cope with the difficulties of being back at work?,
(v) you have learned different ways to cope with your
pain so that you can stay at work?, (vi) you are taking
steps to prevent having to go off job again due to your
injury?, (vii) you have found strategies to make your
work manageable so you can stay at work?, (viii) you are
back at work but are not sure you can keep up the ef-
fort?, (ix) you worry about having to stop working again
due to your injury?, (x) you still find yourself struggling
to stay at work due to the effects of your injury?, (xi)
you are back at work and it is going well?, (xii) you feel
you may need help in order to stay at work?. Each item
is scored on a five point ordinal scale (1 = strongly dis-
agree) to (5 = strongly agree). Mean scores are calculated
and forms four underlying stages for those not returned
to work: Precontemplation, Contemplation, Preparation
for action - self-evaluative, and Prepared for action - be-
havioural. And two stages for those already returned to
work: Uncertain maintenance and proactive mainten-
ance. The stage obtaining the highest mean score is
interpreted as the current stage of readiness. The score
of the R-RTW scale is immediately calculated in the on-
line questionnaire. Measurements will be repeated after
three and twelve months.
Outcomes
Primary
The primary outcome is RTW among cancer survivors in
the intervention group compared with the control group.
RTW is defined by at least 4 consecutive weeks of no
social transfer payments or attending a modified job
called “flexi job”.
The outcome is identified in a national register on weekly
public transfer payments called the Danish Register for
Evaluation of Marginalisation (DREAM) which has been
found to provide valid information on labour market out-
comes [55, 56]. Four consecutive weeks of no social transfer
payments are considered to be equivalent to RTW along
with four consecutive weeks of transfer payment equivalent
to attending a “flexi job”.
Secondary
The secondary outcomes are whether socioeconomic
status or co-morbidity is modifying the effect of the
intervention on RTW.
Socioeconomic status is defined by type of work, edu-
cational level and last year household income before
taxes, which are collected from Statistics Denmark [57].
Co-morbidity is defined by the Charlson-index; a
weighted index including the number and seriousness
of co-morbid diseases [58]. Data on diagnosis used in
the Charlson-index are collected from the National Pa-
tient Registry in Denmark [59].
Sample size calculation
The sample size calculation is based on the primary out-
come RTW.
Approximately 450 patients are annually referred to
the oncology ward with the eligible cancer diagnosis of
which 20 % reside in the two intervention municipalities.
It is expected that the employment rate among cancer
patients would correspond to that of the Danish back-
ground population equivalent to approximately 80 %
[60]. Furthermore, it was anticipated that 80 % gave in-
formed consent to participate in the study. Hence, an
expected number of 288 cancer patients per year. We
estimated a mortality rate of 10 % during the one-year
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follow-up. Based on previous studies the RTW rate
among cancer survivors who underwent occupational re-
habilitation is approximately 82 % [18], and that the
share will be approximately 60 % in the control group
[61, 62]. The hazard ratio (HR) is then given by: (HR: ln
(40 %) / ln (18 %) = 1.87). With a power of 90 % and a
significance level of 5 % a required sample size of 290
patients is needed. To obtain sufficient strength in the
adjusted analyzes 250 survivors should RTW. Thus, the
total number of cancer survivors required is 430 (of
which 90 reside in the two intervention municipalities)
which means an inclusion period of 1.5 years.
Statistical analyses
Primary outcome
The cumulative incidence proportion (CIP) as a function
of the number of follow-up weeks is estimated using the
Kaplan-Meier curve. The relative cumulative incidence
of RTW within 52 weeks will be analyzed in a general-
ised linear regression model using the pseudo values
method [63, 64].
Entry time is defined as the end of cancer treatment
(identified from the hospital records) and the end of
follow-up is 52 weeks following entry time. The outcome
variable RTW consists of two measures: an event indica-
tor (yes or no) and the time until RTW is identified in
the DREAM register [65] or end of follow-up / compet-
ing risks (early retirement benefit, retirement pension or
death)/censored observations (emigration), whichever
comes first.
Adjustments for gender, age, cancer diagnosis, time
since diagnosis and Charlson’s co-morbidity index [58] are
going to be carried out. Moreover, analyses of whether
socio-economic status or Charlson’s co-morbidity index
modifies the effect of the intervention on RTW will also
be carried out.
The significance level is set at p < 0.05. The results will
be shown as crude and adjusted relative cumulative inci-
dences, i.e. risks (RR) and corresponding 95 % confi-
dence intervals (95 % CI).
STATA version 13.1 will be used as statistical software.
Ethical considerations
The study has been notified to and registered by the
Danish Data Protection Agency (nr. 1-16-02-657-14).
Approval from the Danish National Committee on Bio-
medical Research Ethics was not relevant as this is only
provided for projects using biological material. Further-
more, the present study does not include biomedical
treatment.
All patients provided informed consent prior to inclu-
sion in the study.
Discussion
This controlled trial uses the existing setting by which
occupational/vocational rehabilitation takes place in
Danish municipalities as of today. Already job consul-
tants are appointed the role as case managers in cases
of long-term sickness absence. Sick leave due to cancer
is however, dealt with in different ways compared to
less serious conditions; partly because of taboo, reluc-
tance of discussing work with a potentially fatally ill
absentee and off cause due to compassion for this per-
son. However, the social security system, i.e. the Sick-
ness Benefit Act and whether the cancer survivor is
entitled to receive sickness benefit may not differenti-
ate between the reasons for sick leave. As a conse-
quence the cancer survivor may lose financial security
while being sick-listed and also lose her or his job in
the long run [7, 26, 27]. Moreover, the cancer survivor
is left on her or his own to deal with these challenges,
despite the fact that the majority of cancer survivors
are motivated for and wishes to RTW [11].
The innovative element of this intervention is the tim-
ing and early onset of the occupational rehabilitation
which is much earlier than usual and that the job con-
sultants are articulating work and take action on the
cancer survivors’ R-RTW and support them in behaviour
change towards RTW. The evaluation of this interven-
tion will point out if this approach in deed increases the
RTW chance compared to the control municipalities.
The intervention will also be evaluated through quali-
tative interviews in terms of its acceptability to stake-
holders and whether the existing setting is appropriate
and whether job consultants are capable of this task.
The knowledge of RTW facilitators and barriers are
quite extensive [2]. However, in the present trial it was
not possible for us to take into account all of these fac-
tors. The cancer-related symptoms and possible disabil-
ities due to treatment are not addressed directly within
our intervention protocol. As the intervention takes
place parallel with cancer treatment all of the cancer
survivors are in contact with the health care system. If
the job consultants identify health-related barriers in re-
lation to RTW, they are intended to suggest the cancer
survivor to get in contact with the treating oncologist or
the general practitioner (GP). As well as the job consul-
tants themselves can contact the health care profes-
sionals for advice.
According to the integrated cancer pathway “Rehabili-
tation and Palliation in Cancer” [16]; each municipality
in Denmark is obliged to provide cancer rehabilitation.
The municipal job consultants are well informed about
the local offered rehabilitation within their municipality.
Therefore we anticipate that health-related issues will be
addressed because the healthcare stakeholders are close
to the survivor and to the job consultants.
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The theory behind our hypothesis that the intervention
will increase RTW chance originates from the stages of
change model [44]. The R-RTW model addresses the mo-
tivational factors of behaviour change towards RTW and
maintenance of work and was validated in a population of
claimants with muscular-skeletal disorders [40]. The scale
has been translated to Norwegian and was validated in a
Norwegian inpatient occupational rehabilitation program
in sick-listed people [66]. The scale was reliable and a valid
tool for the RTW prognosis.
In Denmark the R-RTW scale is currently being
validated. The data from this study will be used in
the validation of responsiveness. It was not possible
to obtain R-RTW scores from the control group in
this study. Thus, the scores obtained from the cancer
survivors in the intervention group are used solely by
the two job consultants to adjust their rehabilitation
to the right stage.
Methodological considerations
The golden standard when effects of an intervention are
to be assessed is the randomised controlled trial (RCT)
[18]. However, when studies are conducted in real set-
tings, like in municipal job centres; recently published
articles from the Danish national return-to-work pro-
gram showed challenges in applying a randomised study
design; i.e. spill over effects between study arms within
the municipality [67–69]. Therefore we chose a con-
trolled study design. When the control municipalities
are to be chosen, high priority will be given to munici-
palities that resemble the RTW rate of the intervention
municipalities the year before our study was initiated,
i.e. 2013. For that purpose official rates from Statistics
Denmark [57] will be used. We may not be able to iden-
tify municipalities which also can supply sufficient num-
bers of cancer patients fulfilling the inclusion and
exclusion criteria. We might need to compromise on
which municipalities to include as controls to get suffi-
cient numbers of cancer survivors, which in turn might
give residual confounding that will lower the internal
validity of our results.
We believe that if the job consultants are to succeed
in their support and help to the cancer survivors and
thereby increase the R-RTW; they must identify barriers
and facilitators in the RTW process and use the ACT in-
spired dialogue. Otherwise they may not be able to en-
gage the cancer survivors in committed actions that are
value-based and make sense to the survivors’ perception
of quality of life (including work). In order for us to keep
track of the compliance with the study protocol; the job
consultants attend monthly supervisions with the psych-
ologist who trained them in the use of ACT and IPS.
Because the intervention takes place in the job consul-
tants usual work setting, we fear that they are at risk of
resuming old work habits and thereby violate the in-
novative elements in our intervention. We anticipate
that the supervisions act as an arena where experiences
are shared and difficult situations are discussed in order
for the job consultants to learn and cope with their new
job tasks and demands.
Due to the described intervention given by the job
consultants it is not possible to blind the cancer survi-
vors nor the job consultants or the person who will per-
form the analyses.
The sample size calculations are based on cancer sur-
vivors being sick-listed at entry time in the analyses. This
means that we may need more than 430 cancer survivors
in total. This might lead to a longer inclusion period
than the anticipated 1.5 years. We anticipate that results
will be available ultimo 2017.
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